PSTX POSEIDA THERAPEUTICS INC COM

Ownership history in Lindbrook Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Lindbrook Capital, LLC reported a position in POSEIDA THERAPEUTICS INC COM (PSTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q4 REDUCED 52 -49 -48.5% 0.00% $499
2021 Q4 INITIATED 101 0.00% $1K
% of Fund (quarterly)

Other funds also holding PSTX

As of 2025 Q3 — sorted by position size

Point72 Middle East FZE 3Y 0.0%
← Back to Lindbrook Capital, LLC Holdings